Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Managing hereditary ovarian cancer.

Maturitas - 20 Nov 2009

Mourits M J, de Bock G H

Abstract excerpt

In this review we present an overview of recent developments in the management of hereditary ovarian cancer. Until recently, intensive screening of the ovaries was recommended to mutation carriers and their first-degree female relatives. However, since screening is not effective in detecting early-stage ovarian cancer, women are counselled for a prophylactic bilateral salpingo-oophorectomy (pBSO) shortly after...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Contraceptives, Oral
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ovarian Neoplasms

Share to Ovariectomy

Share to Risk Factors

Source

Identifiers

PMID: 19811881
DOI: 10.1016/j.maturitas.2009.09.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Managing hereditary ovarian cancer.PMID 19811881Read ↗

Managing hereditary ovarian cancer risk.Semantic proximity Read ↗

Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal.Semantic proximity Read ↗

Managing hereditary breast cancer risk in women with and without ovarian cancer.Semantic proximity Read ↗

Ovarian cancer risk management in BRCA-mutation carriers: A comparison of six international and national guidelines.Semantic proximity Read ↗

[Management of hereditary ovarian cancer].Semantic proximity Read ↗

[Management of families at high risk for hereditary breast-ovarian cancers: the endocrinologist's point of view].Semantic proximity Read ↗

Hereditary ovarian cancer--assessing risk and prevention strategies.Semantic proximity Read ↗

Identifying and managing hereditary risk of breast and ovarian cancer.Semantic proximity Read ↗

Ovarian cancer: identifying and managing familial and genetic risk-summary of new NICE guidance.Semantic proximity Read ↗

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: An evidence-based approach on what women should know.Semantic proximity Read ↗

[Clinical Management of HBOC in Our Hospital].Semantic proximity Read ↗

Management of hereditary breast and ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.